Hua LIN, Li-xian YUAN, LI-hui GAO, et al. Effect of Mangiferin on mRNA Expressions of Hepatic PRPS, PRPPAT and Cerebral HGPRT in Hyperuricemic Mice Induced by Potassium Oxonate[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(2): 55-59.
DOI:
Hua LIN, Li-xian YUAN, LI-hui GAO, et al. Effect of Mangiferin on mRNA Expressions of Hepatic PRPS, PRPPAT and Cerebral HGPRT in Hyperuricemic Mice Induced by Potassium Oxonate[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(2): 55-59. DOI: 10.13422/j.cnki.syfjx.20190292.
Effect of Mangiferin on mRNA Expressions of Hepatic PRPS, PRPPAT and Cerebral HGPRT in Hyperuricemic Mice Induced by Potassium Oxonate
To investigate the effect of mangiferin on the mRNA expression of phosphoribosylpyrohoosphate synthetase (PRPS)
phosphate ribose pyrophosphate amide transferase (PRPPAT) in liver and hypoxanthine-guanine phosphate transfer enzyme (HGPRT) in brain of hyperuricemic mice induced by potassium oxonate.
Method:
2
Hyperuricemic mice were induced through intraperitoneal injection with uricase inhibitor potassium oxonate. The serum uric acid level was determined by the phosphotungstic acid method. The mRNA expression levels of PRPS and PRPPAT in liver as well as HGPRT in brain of hyperuricemic mice were measured by reverse transcriptase polymerase chain reaction (RT-PCR).
Result:
2
An intraperitoneal injection with potassium oxonate caused a marked increase in serum uric acid level
compared with normal control group (
P
<
0.05). Intragastric administration with mangiferin at the doses of 1.5
3.0
6.0 mg·kg
-1
was able to significantly reduce serum uric acid levels
compared with hyperuricemic control group (
P
<
0.05
P
<
0.01); Moreover
the increase in the mRNA expression levels of PRPS and PRPPAT in liver
as well as the decrease in the mRNA expression of HGPRT in brain were observed in hyperuricemic control group
but with no statistically difference. Mangiferin has no impact on the mRNA expressions of PRPS
PRPPAT and HGPRT
compared with hyperuricemic control group.
Conclusion:
2
The hyporuricemic effect of mangiferin might not be related with PRPS
PRPPAT and HGPRT in therapeutic dose.
关键词
Keywords
references
Lee J M , Kim H C , Cho H M , et al . Association between serum uric acid level and metabolic syndrome [J]. Prev Med Public Health , 2012 , 45 ( 3 ): 181 - 187 .
Zoccali C , Mallamaci F. Uric acid, hypertension, and cardiovascular and renal complications [J]. Curr Hypertens Rep , 2013 , 15 ( 6 ): 531 - 537 .
Boban M , Kocic G , Radenkovic S , et al . Circulating purine compounds, uric acid, and xanthine oxidase/dehydrogenase relationship in essential hypertension and end stage renal disease [J]. Ren Fail , 2014 , 36 ( 4 ): 613 - 618 .
Hsu K C , WANG F S. Fuzzy optimization for detecting enzyme targets of human uric acid metabolism [J]. Bioinformatics , 2013 , 29 ( 24 ): 3191 - 3198 .
Maiuolo J , Oppedisano F , Gratteri S , et al . Regulation of uric acid metabolism and excretion [J]. Int J Cardiol , 2016 , 213 : 8 - 14 .
LI H G , HOU P Y , ZHANG X , et al . Hypouricemic effect of allopurinol are improved by pallidifloside D based on the uric acid metabolism enzymes PRPS, HGPRT and PRPPAT [J]. Fitoterapia , 2016 , 113 : 1 - 5 .
Tabunoki H , Ono H , Ode H , et al . Identification of key uric acid synthesis pathway in a unique mutant silkworm Bombyx mori model of Parkinson's disease [J]. PLoS One , 2013 , 8 ( 7 ): e69130 .
Analysis of Hypouricemic Mechanism of Mangiferin Based on Intestinal Urate Transporter ABCG2
Mechanisms of Intestinal Microecology in Hyperuricemia and Traditional Chinese Medicine Intervention:A Review
Treatment of Hyperuricemia and Gouty Arthritis by Buyang Huanwu Tongfeng Decoction via Inhibition of PPAR-γ/NF-κB/AGEs/RAGE Pathway Based on Network Pharmacology
Exploring Efficacy and Mechanism of Saffron Floral Bio-residues for Treatment of Hyperuricemia Combined with Gouty Arthritis Based on Compound Compatibility Environment
Shenling Baizhusan Improves Spermatogenesis in Hyperuricemia Oligoasthenospermia Mice by Regulating Nrf2/ARE Pathway
Related Author
XU Xiang-wei
NIU Yan-fen
GAO Li-hui
LI Ling
LIN Hua
FAN Mingyuan
YUAN Jiuzhu
XIE Hongyan
Related Institution
TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Chengdu University of TCM
Hospital of Chengdu University of Traditional Chinese Medicine (TCM)
Shanxi University of Chinese Medicine
Prescription and Drug Compatibility and Function Research Laboratory Supported by Shanxi Provincial Administration of TCM,Shanxi University of Chinese Medicine
Experimental Research Center,China Academy of Chinese Medical Sciences